The Kenyan government will next month roll out a new drug meant to protect HIV-negative people from contracting the virus. The drug, known as Pre-exposure Prophylaxis will be taken by HIV negative people who are mostly at risk of HIV infection and is said to reduce the risk of HIV infection with up to 96 per cent
The targeted population for the roll-out include discordant couples, where the HIV-negative partner can be put on the drug, people with multiple sexual partners, individuals who have had sexually transmitted infections (STIs), people who inject drugs, people who have had recurrent use of post-exposure prophylaxis (PEP), sex workers and those who do not use condoms consistently.
The head of National AIDS and STI Control Program, Dr Martin Sirengo, however noted that although the drug will also be available to anybody who wishes to use it, they will need to be assessed by a healthcare provider before being given the prescription only medicine.
Kenya is the second country after South Africa to roll out the program said to reduce the risk of HIV infection in people who are at high risk by up to 92 per cent if taken consistently.